[Endografts (or stent-grafts) and diseases of the descending thoracic aorta].
The endovascular treatment of aorta diseases with S-Graft is considered as an alternative to surgery, especially interesting in patients with severe comorbidities. Indeed, the mid-term morbidity and mortality are comparable to surgery in relatively large series, and S-Graft implantation appeared as a safe, less invasive and efficient treatment for different affections of the thoracic aorta. This article reviews technical aspects, indications and results of endovascular repairs of thoracic aorta lesions. We will also assess the advantages and limitations of S-Graft therapy.
Rousseau
H
H
Services de radiologie, chirurgie cardiovasculaire et cardiologie, hôpital Rangueil, Toulouse. rousseau.h@chu-toulouse.fr
Marcheix
B
B
Chabbert
V
V
Dambrin
C
C
Cron
C
C
Leobon
B
B
Conil
C
C
Massabuau
P
P
Otal
P
P
Joffre
F
F
D000714:Anastomosis, Surgical; D001013:Aorta, Thoracic / Q000601:surgery*; D001018:Aortic Diseases / Q000401:mortality / Q000601:surgery*; D001157:Arterial Occlusive Diseases / Q000601:surgery; D002339:Carotid Arteries / Q000601:surgery; D006801:Humans; D015607:Stents; D013348:Subclavian Artery / Q000473:pathology; D016019:Survival Analysis; D016896:Treatment Outcome